APOTHEEK M. DOBBELS
0841.908.827 · rovalta.com · 25/09/2026
NORMAL SITUATION
APOTHEEK M. DOBBELS
Company — Normal situation.
Strike-off: 18 septembre 2026
Financial year 2025 · Closed on 31/12/2025
Net result-3,2 k €-107,0 %over 1 year
Gross margin-1,4 k €-102,1 %over 1 year
Equity379,1 k €-0,8 %over 1 year
Overview
Identity
Source · BCE/KBOAPOTHEEK M. DOBBELS is a Private limited company incorporated in 2011.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0841.908.827
- Incorporation
- 14/12/2011
- Legal form
- Private limited company
- Contributed capital
- 40 000,00 €
- Latest accounts
- 31/12/2025
Joint committees (1)
- 313
Signals
Solid equityGood liquidity
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -1,4 k € | -102% | 66,5 k € | -21.0% | 84,1 k € | -34.5% | 128,4 k € | +5.4% | 121,8 k € |
| EBITDA | -2 k € | -103% | 61,3 k € | -17.1% | 74 k € | -38.0% | 119,2 k € | +5.3% | 113,2 k € |
| Operating result | -2,8 k € | -105% | 60 k € | -16.4% | 71,7 k € | -38.7% | 117 k € | +93.8% | 60,4 k € |
| Net result | -3,2 k € | -107% | 45 k € | -18.9% | 55,5 k € | -32.9% | 82,7 k € | +89.6% | 43,6 k € |
| Balance sheet | |||||||||
| Equity | 379,1 k € | -0.8% | 382,3 k € | +13.4% | 337,2 k € | +18.9% | 283,7 k € | +39.8% | 203 k € |
| Total assets | 380 k € | -2.4% | 389,5 k € | -1.0% | 393,5 k € | -1.7% | 400,3 k € | +10.3% | 363 k € |
| Cash | 147,5 k € | -31.2% | 214,3 k € | +60.3% | 133,7 k € | -26.2% | 181,1 k € | +18.7% | 152,5 k € |
| Debts | 884,6 € | -87.0% | 6,8 k € | -87.9% | 56,3 k € | -51.7% | 116,6 k € | -27.1% | 160 k € |
| Other | |||||||||
| Workforce | – | 0,2 ETP | 0.0% | 0,2 ETP | 0.0% | 0,2 ETP | 0.0% | 0,2 ETP | |
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Active
Ended mandates
Bart Vandeweghe
EndedMarijke Dobbels
EndedMarijke Dobbels
EndedFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/07/2026 | 28/08/2025 | 27/06/2024 | 04/07/2023 | 04/07/2022 | 24/06/2021 |
| General meeting | 30/06/2026 | 31/07/2025 | 01/06/2024 | 01/06/2023 | 01/06/2022 | 01/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/06/2026 | 23/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 31/07/2025 | 28/08/2025 | Dutch | |
| Abridged model | 31/12/2023 | 01/06/2024 | 27/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 01/06/2023 | 04/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 01/06/2022 | 04/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 01/06/2021 | 24/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 01/06/2020 | 27/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 01/06/2019 | 23/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 01/06/2018 | 23/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 01/06/2017 | 28/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 01/06/2016 | 29/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 01/06/2015 | 27/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 01/06/2014 | 03/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 01/06/2013 | 21/06/2013 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Active
Ended mandates
Bart Vandeweghe
EndedMarijke Dobbels
EndedMarijke Dobbels
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates24/10/2024MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Mandates28/03/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
- Mandates18/07/2016BENAMING - ONTSLAGEN - BENOEMINGEN
- Other29/12/2011RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-3,2 k €↓
- 2024Annual accounts 202445 k €↓
- 2024Name changeDobbels M.Apotheek
- 2023Annual accounts 202355,5 k €↓
- 2022Annual accounts 202282,7 k €↑
- 2021Annual accounts 202143,6 k €↑
- 2021Name changeApotheek M. Dobbels
- 2020Annual accounts 202039,3 k €↑
- 2019Annual accounts 201939,1 k €↑
- 2018Annual accounts 201814,7 k €↓
- 2017Annual accounts 201723,3 k €↑
- 2016Annual accounts 201614,8 k €↑
- 2015Annual accounts 20158,7 k €↑
- 2014Annual accounts 2014-1,5 k €↓
- 2013Annual accounts 201326,5 k €↑
- 2012Annual accounts 201210,8 k €
- 14/12/2011IncorporationPrivate limited company